Key result
Silencing of mIGF1 in a rat model of atrial fibrillation significantly prolonged the atrial effective refractory period and reduced AF inducibility by attenuating atrial fibrosis.
Why the study?
Structural remodeling is critical to the initiation and maintenance of AF, but the roles and mechanisms of IGF1 in structural remodeling during AF remain unclear.
Does IGF1 silencing reduce atrial fibrosis and AF inducibility in rat models?
Does IGF1 silencing reduce atrial fibrosis and AF inducibility in rat models?
Absolute Event Rate: 76.5% vs 60.5%
p-value: p=<0.01
IGF1 promotes atrial fibrosis and AF inducibility via the PI3K-Akt pathway, highlighting a potential therapeutic target for AF.
BACKGROUND: Structural remodeling is critical to the initiation and maintenance of atrial fibrillation (AF). IGF1, insulin like growth factor 1, has been recognized as contributor to fibrosis. However, the roles and mechanisms of IGF1 in structural remodeling during AF is still unclear. METHODS: We investigated the transcriptional expression profiles of left atria in AF and non-AF rat models by using microarray analysis. And quantitative real-time polymerase chain reaction (qRT-PCR) was performed to validate the accuracy. After bioinformatics analysis, IGF1 was selected to explore its effects and mechanisms on atrial fibrosis. The fibroblasts were extracted from atria of rats, and randomly divided into negative control group, mIGF1 overexpression group and mIGF1 silencing group. Then 30 healthy male Wistar rats were randomly divided into negative control group (n = 10), pacing group (n = 10), pacing + mIGF1 silencing viruses group (n = 10). Then the intracardiac electrophysiological examination, qRT-PCR, Western Blotting, masson staining were conducted after IGF1 interfering experiments. RESULTS: A total of 956 differentially expressed transcripts were identified, in which 395 transcripts were down-regulated and 561 transcripts were up-regulated. Bioinformatics analysis was conducted to predict the functions and interactions of the aberrantly expressed genes. The inhibition of IGF1 function in AF model could ameliorate the inducibility of AF. The IGF1 plays a fibrotic role by activating the PI3K-Akt pathway to increase the expression of CTGF and AT1R. CONCLUSIONS: IGF1 develops vital function in regulating structural remodeling during AF, which could illustrate the mechanism of AF pathogenesis and supply potential targets for its precise treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied Atrial Fibrillation (n=50). mIGF1 silencing adeno-associated viruses (AAV) vs. Negative control AAV (pacing group) was evaluated on Atrial effective refractory period (AERP) in ms (p=<0.01). Silencing of mIGF1 in a rat model of atrial fibrillation significantly prolonged the atrial effective refractory period and reduced AF inducibility by attenuating atrial fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: